Controller
Osanni Bio
Controller
Osanni Bio
Development-stage therapeutics platform advancing drug programs
Who We Are:
Osanni is a development-stage therapeutics platform, headquartered in San Francisco, California. We are creative and agile innovators, relentlessly curious about finding new ways to target the biology behind diseases with the greatest unmet need and determined to do something about it.
At the center of Osanni is its innovation engine, which is optimized for discovering new scientific insights, designing novel drug concepts, and efficiently advancing programs to a meaningful proof-of-concept. Once a program is sufficiently de-risked, it graduates into its ecosystem of affiliate companies (called Avians), which are equipped with the dedicated focus, specialized talent and support necessary to scale. Osanni's architecture marries the scientific depth and operational power of a centralized platform with the speed, agility and accountability of independent companies. The result: an opportunity to create and deliver more transformative medicines.
We hold patients and the physicians who care for them as our North Star. It guides our purpose, sharpens our decision-making, and defines our impact. Osanni is currently advancing programs in ophthalmology, cardiology and beyond. We are building a highly skilled team, passionate about having an impact on human health. Be part of creating an organization where people enjoy their work and their colleagues, are valued for their individuality, and can't imagine working anywhere else.
This role is based in the San Francisco Bay Area and requires working on-site 3 days/week.
About the Role
The Controller is responsible for leading Osanni's accounting operations across the hub and its Avians, owning the close, consolidation, internal controls, audit, and technical accounting that give leadership an accurate, timely view of each entity's financial position. Reporting to the CFO, this role builds the multi-entity accounting infrastructure that allows our hub-and-Avian model to scale as new Avians are formed, financed, and partnered. As Osanni grows, the Controller will be a key partner to the CFO, FP&A, and functional leaders in supporting financings, business development, and sound capital allocation decisions.
The ideal candidate brings strong technical accounting judgment paired with a builder's mindset, comfortable designing scalable processes and rolling up their sleeves to execute them. They hold themselves to a high standard of accuracy and integrity, and they thrive in ambiguity, adapting quickly as priorities shift in a fast-paced, evolving biotech environment. A collaborative communicator, they translate complex financial information into clear insights for scientific, operational, and executive partners across the organization.
What You Will Do
What You Bring
#LI-hybrid
Below is the expected base pay range for this position plus bonus and comprehensive benefits. The base pay range reflects the target range for this position, but individual pay will be determined by additional factors such as job-related skills, experience and relevant education or training.
We are committed to creating a diverse environment and are proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
We will provide an intellectually stimulating, collegial and fast-paced environment. If you are ready to be a part of building the future of transformative medicines, then we are excited to hear from you!
Base Pay 260000 - 285000 USD
Development-stage therapeutics platform advancing drug programs
Osanni Bio uses a centralized innovation engine paired with a network of affiliate companies to discover, de-risk, and advance drug programs to proof-of-concept, then spins out successful programs as independent companies to scale. It generates drug concepts and progresses them to PoC through its central research engine and affiliate network. Unlike traditional pharma pipelines, it combines central science with a spin-out model to pursue capital-efficient, rapid PoC development. Its goal is to accelerate medicines in ophthalmology and cardiology with efficient progression to PoC and scalable programs.
Explore more opportunities at Osanni Bio